GlassScriptPhysician profile
Joseph C Banis
NPI 1093717274
$15,377.11
in general payments reported to CMS, 2019-2025
21 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what 82% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,455 · 2020: $897 · 2021: $2,883 · 2022: $2,534 · 2023: $3,387 · 2024: $2,442 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,207 · Food and Beverage: $2,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,207.10 |
| Food and Beverage | $2,402.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,044.01 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Allergan, INC. | $4,614.31 | 2019-2023 | |
| Merz North America, INC. | $3,290.81 | 2019-2025 | Xeomin |
| Sientra, INC. | $706.91 | 2019-2022 | |
| Rti Surgical, INC | $673.24 | 2023-2025 | |
| Revance Therapeutics, INC. | $168.80 | 2024-2025 | Daxxify |
| Musculoskeletal Transplant Foundation INC. | $154.62 | 2020 | |
| Smith+Nephew, INC. | $123.05 | 2019-2024 | Stravix, Grafix Pl, Renasys Touch |
| Bsn Medical INC | $121.90 | 2023 | |
| Integra Lifesciences Corporation | $119.13 | 2019-2021 | |
| Galderma Laboratories, L.P. | $74.65 | 2019-2023 | |
| Polymedics Innovations INC. | $58.04 | 2023 | |
| Organogenesis INC. | $52.11 | 2019-2023 | Puraply |
| Baudax Bio INC. | $33.40 | 2021 | |
| Merck Sharp & Dohme LLC | $23.86 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $23.43 | 2022 | |
| Tei Biosciences INC | $23.25 | 2019 | |
| Motiva USA, LLC | $21.03 | 2025 | |
| Tela Bio, INC. | $20.33 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $17.58 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Banis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.